Keyphrases
Diffuse Large B-cell Lymphoma (DLBCL)
100%
Double Hit
100%
Single Hit
100%
Triple Hit
100%
Subsequent Therapy
100%
Refractory Diffuse Large B-cell Lymphoma
100%
Salvage Therapy
80%
Hematopoietic Cell Transplantation
60%
B-cell Lymphoma 2 (Bcl-2)
40%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
40%
Confidence Interval
40%
Hazard Ratio
40%
Overall Survival Rate
40%
Primary Treatment Failure
40%
Multicenter Retrospective Study
20%
High Risk
20%
BCL6
20%
Cell Survival
20%
Transplant Outcomes
20%
Chemoimmunotherapy
20%
Complete Remission
20%
Well-defined
20%
Response Rate
20%
Overall Response Rate
20%
Basic Helix-loop-helix (bHLH)
20%
Risk of Death
20%
Survival Outcomes
20%
Unmet Medical Need
20%
MYC Proto-oncogene
20%
MYC Translocation
20%
BCL6 Rearrangement
20%
Adjusting for Covariates
20%
Medicine and Dentistry
Diffuse Large B-Cell Lymphoma
100%
Hematopoietic Cell
83%
Cell Transplantation
83%
Salvage Therapy
66%
B-Cell Lymphoma
33%
Hazard Ratio
33%
Overall Survival
33%
Survival Rate
33%
Helix
33%
Malignant Neoplasm
16%
Cell Survival
16%
Proto Oncogene
16%
Retrospective Study
16%
Chemoimmunotherapy
16%